Evidence map›Paper›PMID 31611759›Full record

ArticleFrontiers in neuroscience2019

S-Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals.

André Schwertner, Maxciel Zortea, Felipe Vasconcelos Torres, Leticia Ramalho, Camila Fernanda da Silveira Alves, Guilherme Lannig, Iraci L S Torres, Felipe Fregni, Gustavo Gauer, Wolnei Caumo

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03915938 (Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03915938 phase2 / phase3completednot on this map

Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: a Placebo-controlled Study in Healthy Male Subjects

TypeinterventionalSponsorHospital de Clinicas de Porto AlegreRan2017 to 2017Enrolled24ConditionsAcute Pain, Chronic Pain, Widespread, SchizophreniaArmsKetamine, Placebo
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

André SchwertnerPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Maxciel ZorteaPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Felipe Vasconcelos TorresPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Leticia RamalhoPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Camila Fernanda da Silveira AlvesPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Guilherme LannigClinical Research Center, Clinical Hospital of Porto Alegre, Porto Alegre, Brazil.
Iraci L S TorresPost-graduation Program in Biological Sciences: Physiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Felipe FregniNeuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, United States.
Gustavo GauerPost-graduation Program in Psychology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Wolnei CaumoPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Universidade Federal do Rio Grande do Sul · BRHospital de Clínicas de Porto Alegre · BRHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies using the electroencephalogram (EEG) technique pointed out that ketamine decreases the amplitude of cortical electrophysiological signal during cognitive tasks, although its effects on the perception and emotional-valence judgment of stimuli are still unknown.

objectiveWe evaluated the effect of S-ketamine on affective dimension of pain using EEG and behavioral measures. The hypothesis was that S-ketamine would be more effective than placebo, both within and between groups, to attenuate the EEG signal elicited by target and non-target words.

methodsThis double-blind parallel placebo-controlled study enrolled 24 healthy male volunteers between 19 and 40 years old. They were randomized to receive intravenous S-ketamine (

resultsS-ketamine produced substantial difference (delta) in the AUC of grand average ERP components N200 (

conclusionOur findings suggest that S-ketamine actively changed the semantic processing of written words. There was an increase in electrophysiological response for pain-related stimuli and a decrease for standard stimuli, as evidenced by the increased delta of AUCs. Behaviorally, S-ketamine seems to have produced an emotional and discrimination blunting effect for pain-related words. CLINICAL

trial registrationwww.ClinicalTrials.gov, identifier NCT03915938.

Indexed as

ERPsketamineoddballP300pain

Identifiers

PMID31611759
PMCPMC6753200
OpenAlexW2970709004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.